BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38242508)

  • 1. Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
    Altibi AM; Sapru A; Ghanem F; Zhao Y; Alani A; Cigarroa J; Nazer B; Song HK; Masri A
    Int J Cardiol; 2024 Apr; 400():131790. PubMed ID: 38242508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Outcomes of Septal Myectomy With and Without Mitral Valve Surgeries in Hypertrophic Cardiomyopathy: a National Propensity-Matched Analysis (2005 to 2020).
    Faisaluddin M; Ahmed A; Patel H; Thakkar S; Patel B; Balasubramanian S; Feitell SC; Shekar P; Rowin E; Maron M; Ganatra S; Dani SS
    Am J Cardiol; 2023 Oct; 205():276-282. PubMed ID: 37619494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Septal Myectomy Volume on Mitral-Valve Replacement Rate in Hypertrophic Cardiomyopathy Patients.
    Polanco AR; D'Angelo A; Shea N; Yu SN; Chiang YP; Shimada Y; Weiner SD; Takayama H
    Cardiology; 2020; 145(3):161-167. PubMed ID: 32007988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Septal Myectomy in Hypertrophic Cardiomyopathy: National Outcomes of Concomitant Mitral Surgery.
    Holst KA; Hanson KT; Ommen SR; Nishimura RA; Habermann EB; Schaff HV
    Mayo Clin Proc; 2019 Jan; 94(1):66-73. PubMed ID: 30611455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of surgical expertise in septal myectomy for obstructive hypertrophic cardiomyopathy.
    Yu SN; Nakanishi K; Ginns JN; Salna MP; Shimada YJ; Polanco A; Chiang Y; Weiner SD; Takayama H
    Gen Thorac Cardiovasc Surg; 2020 Oct; 68(10):1094-1100. PubMed ID: 32103394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hospital readmission rates as a quality metric in adult cardiac surgery.
    Ebrahimian S; Bakhtiyar SS; Verma A; Williamson C; Sakowitz S; Ali K; Chervu NL; Sanaiha Y; Benharash P
    Heart; 2023 Sep; 109(19):1460-1466. PubMed ID: 37258097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding Surgical Edge-to-Edge Mitral Valve Repair to Myectomy in Hypertrophic Obstructive Cardiomyopathy: Long-Term Functional and Echocardiographic Outcome.
    Hegeman RRMJJ; Heeringa T; Beukers SHQ; Van Kuijk JP; Guglielmo M; Ten Berg JM; Swaans MJ; Klein P
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102134. PubMed ID: 37852558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Surgical Management of Hypertrophic Cardiomyopathy in the United States.
    Wei LM; Thibault DP; Rankin JS; Alkhouli M; Roberts HG; Vemulapalli S; Yerokun B; Ad N; Schaff HV; Smedira NG; Takayama H; McCarthy PM; Thourani VH; Ailawadi G; Jacobs JP; Badhwar V
    Ann Thorac Surg; 2019 Feb; 107(2):460-466. PubMed ID: 30326232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy?
    Lentz Carvalho J; Schaff HV; Nishimura RA; Ommen SR; Geske JB; Lahr BD; Newman DB; Dearani JA
    J Thorac Cardiovasc Surg; 2023 Jan; 165(1):79-87.e1. PubMed ID: 33632527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical treatment of obstructive hypertrophic cardiomyopathy with ventricular septal myectomy concomitant mitral valve replacement].
    WANG R; CHEN X; XU M; SHI KH; WANG LM; XIAO LQ; LIU PS
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1572-4. PubMed ID: 19094655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Trends and Outcomes of Surgical Aortic Valve Replacement With Concomitant Mitral Valve Surgery.
    Arshad HB; Minhas AMK; Khan SU; Nasir K; Rao N; Thacker S; Butt SA; Faza N; Little SH; von Ballmoos MW; Kleiman NS; Reardon MJ; Kapadia SR; Goel SS
    Cardiovasc Revasc Med; 2022 Jul; 40():13-19. PubMed ID: 34801422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysis.
    Ullah W; Sarvepalli D; Kumar A; Zahid S; Saleem S; Muhammadzai HZU; Khattak F; Block PC; Jaber WA; Shishehbor MH; Filby SJ; Devireddy C
    Catheter Cardiovasc Interv; 2023 Nov; 102(5):946-957. PubMed ID: 37698396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results.
    Heric B; Lytle BW; Miller DP; Rosenkranz ER; Lever HM; Cosgrove DM
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):195-206; discussion 206-8. PubMed ID: 7609544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined mechanical mitral valve replacement and transmitral myectomy for hypertrophic obstructive cardiomyopathy treatment: An experience of over 20 years.
    Shimahara Y; Fujita T; Kobayashi J; Fukushima S; Kume Y; Yamashita K; Matsumoto Y; Kawamoto N; Tadokoro N; Kakuta T; Kanzaki H; Amaki M
    J Cardiol; 2019 Apr; 73(4):318-325. PubMed ID: 30583989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the best surgical treatment for obstructive hypertrophic cardiomyopathy and degenerative mitral regurgitation?
    Wan CK; Dearani JA; Sundt TM; Ommen SR; Schaff HV
    Ann Thorac Surg; 2009 Sep; 88(3):727-31; discussion 731-2. PubMed ID: 19699887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors and Outcomes of Patients Requiring a Permanent Pacemaker After Aortic Valve Replacement in the United States.
    Robich MP; Schiltz NK; Johnston DR; Mick S; Krishnaswamy A; Iglesias RA; Hang D; Roselli EE; Soltesz EG
    J Card Surg; 2016 Aug; 31(8):476-85. PubMed ID: 27335256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The surgical management of hypertrophic obstructive cardiomyopathy with the concomitant mitral valve abnormalities.
    Cui B; Wang S; Xu J; Wang W; Song Y; Sun H; Zheng Z; Lv F; Xiong H
    Interact Cardiovasc Thorac Surg; 2015 Dec; 21(6):722-6. PubMed ID: 26374266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Hospital Volumes in Identifying Low-Performing and High-Performing Aortic and Mitral Valve Surgical Centers in the United States.
    Khera R; Pandey A; Koshy T; Ayers C; Nallamothu BK; Das SR; Drazner MH; Jessen ME; Kirtane AJ; Gardner TJ; de Lemos JA; Bhatt DL; Kumbhani DJ
    JAMA Cardiol; 2017 Dec; 2(12):1322-1331. PubMed ID: 29117319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume-outcome relationship in septal myectomy for hypertrophic obstructive cardiomyopathy.
    Hadaya J; Verma A; Sanaiha Y; Shemin RJ; Benharash P
    Surgery; 2023 Aug; 174(2):166-171. PubMed ID: 37230867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
    Reardon MJ; Heijmen RH; Van Mieghem NM; Williams MR; Yakubov SJ; Watson D; Kleiman NS; Conte J; Chawla A; Hockmuth D; Petrossian G; Robinson N; Kappetein AP; Li S; Popma JJ
    JAMA Cardiol; 2019 Aug; 4(8):810-814. PubMed ID: 31215985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.